# EDGAR Filing Document

**Accession Number:** 0000860730
**File Stem:** 0001193125-26-041430
**Filing Date:** 2026-2
**Character Count:** 13660
**Document Hash:** 6e9b8b1a6ef8838fde2543439b7e25c9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-041430.hdr.sgml**: 20260206

**ACCESSION NUMBER**: 0001193125-26-041430

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260201

**FILED AS OF DATE**: 20260206

**DATE AS OF CHANGE**: 20260206

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Rossitto Erica
- **CENTRAL INDEX KEY:** 0002108748

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11239
- **FILM NUMBER:** 26608869

**MAIL ADDRESS:**
- **STREET 1:** ONE PARK PLAZA
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HCA Healthcare, Inc.
- **CENTRAL INDEX KEY:** 0000860730
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 273865930
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** ONE PARK PLZ
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203
- **BUSINESS PHONE:** 6153449551

**MAIL ADDRESS:**
- **STREET 1:** ONE PARK PLAZA
- **CITY:** NASHVILLE
- **STATE:** TN
- **ZIP:** 37203

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HCA Holdings, Inc.
- **DATE OF NAME CHANGE:** 20101126

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HCA INC/TN
- **DATE OF NAME CHANGE:** 20010627

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HCA THE HEALTHCARE CO
- **DATE OF NAME CHANGE:** 20010419

## Ex-24

**<br>POWER OF ATTORNEY** 

**KNOW ALL PERSONS BY THESE PRESENTS,** that the undersigned hereby makes, constitutes and appoints John M. Franck II, Natalie Harrison Cline and Kevin A. Ball, in each case so long as he or she is employed by an affiliate of HCA Healthcare, Inc. (the "Company"), as the undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) prepare, execute, acknowledge, deliver and file a Form ID (including any amendments or authentications thereto) with respect to obtaining EDGAR codes and enrolling the undersigned in EDGAR Next, with the U.S. Securities and Exchange Commission;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) prepare, execute, acknowledge, deliver and file, or cause them to be submitted and filed by a person appointed under Section 3 below, Forms 3, 4 and 5 (including any amendments thereto) with respect to the securities of the Company, with the U.S. Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"), or under Rule 144 under the Securities Act of 1933 ("Rule 144"), including Forms 3, 4 and 5, Schedules 13D and 13G, and Forms 144;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) as applicable, either (a) act as an account administrator for the undersigned's EDGAR account, including the authority and power to: (i) appoint, remove and replace account administrators, account users, technical administrators and delegated entities; (ii) maintain the security of the undersigned's EDGAR account, including modification of access codes; (iii) maintain, modify and certify the accuracy of information on the undersigned's EDGAR account dashboard; (iv) act as the EDGAR point of contact with respect to the undersigned's EDGAR account; and (v) any other actions contemplated by Rule 10 of Regulation S-T with respect to account administrators; or (b) act as a delegated administrator for the undersigned's EDGAR account, including the authority and power to: (i) appoint, remove and replace delegated account administrators and users; (ii) maintain the security of the undersigned's EDGAR account; and (iii) any other actions contemplated by Rule 10 of Regulation S-T with respect to delegated entities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) cause the Company to accept a delegation of authority from any of the undersigned's EDGAR account administrators and, pursuant to that delegation, authorize the Company's EDGAR account administrators to appoint, remove or replace users for the undersigned's EDGAR account;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

The undersigned acknowledges that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) this Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on information provided to such attorneys-in-fact without independent verification of such information;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) any documents prepared and/or executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) neither the Company nor such attorneys-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirements of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act.

The undersigned hereby gives and grants the foregoing attorneys-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, with full power of substitution and revocation, hereby ratifying all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Power of Attorney.

------

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to

such attorneys-in-fact.

<br> **IN WITNESS WHEREOF,** the undersigned has caused this Power of Attorney to be executed as of this 20th day of January 2026.

/s/ Erica Rossitto

STATE OF TENNESSEE

COUNTY OF DAVIDSON

Personally appeared before me, the undersigned, a Notary Public having authority within the State and County aforesaid, Erica Rossitto, with whom I am personally acquainted (or proved to me on the basis of satisfactory evidence), and who acknowledged that she executed the within instrument for the purposes therein contained.

WITNESS my hand, at office, this 20 day of January, 2026.

/s/ Sharon Hall

NOTARY PUBLIC

My Commission Expires: 9.5.28

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Rossitto Erica<br><sub>(Last) (First) (Middle)</sub><br>ONE PARK PLAZA<br><sub>(Street)</sub><br>NASHVILLE, TN 37203<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>HCA Healthcare, Inc. [ HCA ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-02-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_SVP & Chief Nurse Executive_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 9149 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | 2027-01-30 | 2033-01-30 | Common Stock | 105 | <sup>(1)</sup> | D |  |
| Restricted Stock Units | <sup>(2)</sup> | 2034-01-31 | Common Stock | 323 | <sup>(1)</sup> | D |  |
| Stock Appreciation Right | <sup>(3)</sup> | 2027-02-01 | Common Stock | 8080 | $81.96 | D |  |
| Stock Appreciation Right | <sup>(4)</sup> | 2028-01-31 | Common Stock | 5040 | $101.16 | D |  |
| Stock Appreciation Right | <sup>(5)</sup> | 2029-01-30 | Common Stock | 3230 | $139.06 | D |  |
| Stock Appreciation Right | <sup>(6)</sup> | 2030-01-29 | Common Stock | 1670 | $145.24 | D |  |
| Stock Appreciation Right | <sup>(7)</sup> | 2030-10-27 | Common Stock | 960 | $130.56 | D |  |
| Stock Appreciation Right | <sup>(8)</sup> | 2031-02-03 | Common Stock | 1840 | $173.12 | D |  |
| Stock Appreciation Right | <sup>(9)</sup> | 2032-01-28 | Common Stock | 1390 | $236.61 | D |  |
| Stock Appreciation Right | <sup>(10)</sup> | 2033-01-30 | Common Stock | 1263 | $253.30 | D |  |
| Stock Appreciation Right | <sup>(11)</sup> | 2034-01-31 | Common Stock | 1859 | $304.90 | D |  |
| Stock Appreciation Right | <sup>(12)</sup> | 2035-01-28 | Common Stock | 2235 | $328.700 | D |  |
| Stock Appreciation Right | <sup>(13)</sup> | 2036-01-29 | Common Stock | 2560 | $482.53 | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.

(2) The restricted stock units vest in two equal annual installments beginning on January 31, 2027.

(3) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

(4) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

(5) The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

(6) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.

(7) The stock appreciation rights vested in four equal annual installments beginning on October 27, 2021.

(8) The stock appreciation rights vested in four equal annual installments beginning on February 3, 2022.

(9) The stock appreciation rights vested in four equal annual installments beginning on January 28, 2023.

(10) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.

(11) The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

(12) The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

(13) The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.

**Signature:** /s/ Kevin A. Ball, Attorney-in-Fact  
**Date:** 2026-02-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**